Related Experiment Videos
Re-OPCAB vs. Re-CABG for myocardial revascularization.
A Schütz1, H Mair, S M Wildhirt
1Department of Cardiac Surgery, Herzklinik am Augustinum, München, Germany. a.schuetz@hch.med.uni-muenchen.de
The Thoracic and Cardiovascular Surgeon
|July 4, 2001
Summary
Redo off-pump coronary artery bypass grafting (Re-OPCAB) shows reduced myocardial damage and shorter intensive care unit stays compared to conventional redo coronary artery bypass grafting (Re-CABG). This minimally invasive technique is a viable alternative for selected patients needing reoperation for myocardial revascularization.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Cardiac Surgery
- Cardiac Revascularization
Background:
- Redo coronary artery bypass grafting (CABG) is complex, with potential for increased myocardial damage.
- Comparing minimally invasive off-pump techniques (Re-OPCAB) with conventional sternotomy (Re-CABG) is crucial for optimizing outcomes.
Purpose of the Study:
- To compare myocardial damage and clinical outcomes between redo off-pump coronary artery bypass grafting (Re-OPCAB) and conventional redo coronary artery bypass grafting (Re-CABG).
Main Methods:
- Retrospective comparison of 20 Re-OPCAB patients (minimally invasive or Octopus technique) with 20 Re-CABG patients.
- Patient demographics, risk factors, and cardiac/renal/liver function were analyzed.
- Surgical parameters, enzyme levels, and clinical outcomes were assessed postoperatively.
Main Results:
- Re-OPCAB demonstrated significantly lower epinephrine requirements and CKMB levels at 24 hours post-operation.
- Patients undergoing Re-OPCAB had shorter extubation times and reduced ICU length of stay.
- No perioperative myocardial infarctions or deaths occurred in either group; 95% graft patency was observed in the Re-OPCAB group.
Conclusions:
- Re-OPCAB leads to decreased cardiac enzyme release and reduced need for inotropes in the early postoperative period.
- This technique offers comparable clinical outcomes to conventional Re-CABG in selected patients requiring reoperation.
- Further large-scale, randomized trials are needed to identify optimal patient selection for each revascularization strategy.